IN8bio(INAB)
$0.82-0.00 (-0.49%)
INAB
IN8bio financials statements
$0.82
At close:-0.00 (-0.49%)
Want to see INAB full AI Analyst Report?
IN8bio (INAB) Ratios
455 Followers
IN8bio Ratios
INAB's free cash flow for Q3 2026 was $-3.93M. For the 2026 fiscal year, INAB's free cash flow was increased by $1.00K and operating cash flow was $-3.93M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 8.82 | 4.08 | 4.57 | 3.82 | 17.28 |
| Quick Ratio | 8.82 | 4.08 | 4.57 | 3.82 | 17.28 |
| Cash Ratio | 8.57 | 3.61 | 3.95 | 3.12 | 16.41 |
| Solvency Ratio | -3.59 | -4.30 | -3.14 | -2.66 | -3.43 |
| Operating Cash Flow Ratio | -4.02 | -7.83 | -4.33 | -4.14 | -5.99 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 23.16M | $ 6.11M | $ 15.85M | $ 11.93M | $ 34.94M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.09 | 0.24 | 0.15 | 0.18 | 0.06 |
| Debt-to-Equity Ratio | 0.10 | 0.35 | 0.20 | 0.26 | 0.06 |
| Debt-to-Capital Ratio | 0.09 | 0.26 | 0.16 | 0.21 | 0.06 |
| Long-Term Debt-to-Capital Ratio | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.17 | 1.45 | 1.35 | 1.45 | 1.11 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.64 | 0.09 | 0.16 | 0.28 | 0.13 |
| Net Debt to EBITDA | 1.44 | 0.23 | 0.60 | 0.45 | 2.50 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 97.88% | 100.00% | 98.91% | 100.00% | 100.00% |
| Return on Assets (ROA) | -60.22% | -145.33% | -89.02% | -86.33% | -34.70% |
| Return on Equity (ROE) | -70.54% | -210.23% | -120.33% | -125.47% | -38.38% |
| Return on Capital Employed (ROCE) | -68.20% | -170.41% | -107.14% | -104.79% | -36.66% |
| Return on Invested Capital (ROIC) | -65.46% | -156.02% | -101.70% | -99.70% | -36.10% |
| Return on Tangible Assets | -60.22% | -145.33% | -89.02% | -86.66% | -34.70% |
| Earnings Yield | -189.92% | -7.36% | -2.43% | -1.96% | -0.59% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 8.09 | 0.00 | 2.71 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -45.10 | 0.00 | -134.85 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 45.10 | 0.00 | 134.85 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -2.91 | -0.45 | -0.78 | -1.15 | -0.72 |
| Free Cash Flow Per Share | -2.91 | -0.45 | -0.80 | -1.33 | -0.74 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -232.20 | -38.90 | -6.51 | -43.72 |
| Capital Expenditure Coverage Ratio | 0.00 | -232.20 | -38.90 | -6.51 | -43.72 |
| Operating Cash Flow Coverage Ratio | -4.57 | -4.80 | -4.77 | -4.11 | -5.61 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -124.19% | -5.87% | -1.94% | -1.91% | -0.56% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.53 | -13.54 | -41.20 | -50.95 | -168.80 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 0.37 | 28.55 | 49.58 | 63.92 | 64.78 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.81 | -17.04 | -51.65 | -52.22 | -179.00 |
| Price-to-Operating Cash Flow Ratio | -0.81 | -17.12 | -52.97 | -60.24 | -183.10 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | 0.31 | 1.56 | -0.69 | -3.58 |
| Enterprise Value Multiple | 0.83 | -15.12 | -44.35 | -52.55 | -175.90 |
| Enterprise Value | -14.07M | 407.29M | 1.22B | 1.44B | 2.44B |
| EV to EBITDA | 0.83 | -15.12 | -44.35 | -52.55 | -175.90 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | 1.11 | -16.79 | -50.96 | -51.78 | -176.50 |
| EV to Operating Cash Flow | 1.11 | -16.87 | -52.27 | -59.73 | -180.54 |
| Tangible Book Value Per Share | 6.30 | 0.27 | 0.83 | 1.08 | 2.03 |
| Shareholders’ Equity Per Share | 6.30 | 0.27 | 0.83 | 1.08 | 2.03 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -4.44 | -0.57 | -1.00 | -1.36 | -0.78 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.03 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.65 | 0.79 | 0.78 | 0.85 | 0.92 |
Currency in USD

